Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05836701

Retrospective Study of Germ Cell Tumors of the Central Nervous System

Retrospectively analyzing the epidemiological and clinical characteristics, treatment, recurrence, prognosis and prognostic factors of the germ-cell tumors of central nervous system in a single center.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Germ Cell Tumor of CNS

Sex eligibility

All sexes

Study type

Observational

Primary location

Sanbo Brain Hospital Capital Medical University

Beijing, China

About this study

Clinical data of patients with germ-cell tumors of central nervous system who were treated in the Department of Neuro-oncology, Sanbo Brain Hospital Capital Medical University between January 2007 and December 2022 were retrospectively collected, and the epidemiological and clinical characteristics, treatment, recurrence, prognosis and prognostic factors of the disease were analyzed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinically or pathologically diagnosed as germ cell tumor of the central nervous system.
  • Have received antitumor therapy.
  • Patients who were clinically diagnosed based on neuroimaging characteristics and response to radiotherapy or chemotherapy were allowed for enrollment.

Exclusion criteria

  • Patients with missing key information such as tumor location, surgical, chemotherapy and radiotherapy data, and post-treatment evaluation.

Treatment and study plan

Primary outcomes

  1. epidemiological characteristics

    Time frame: 1 year

  2. treatment regimen

    Time frame: 1 year

  3. relapse pattern

    Time frame: 1 year

  4. prognostic factor

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Beijing Sanbo Brain Hospital

Other

Registry information

Official study title

Single-center Retrospective Study of Germ Cell Tumors of the Central Nervous System

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
May 1, 2023
Registry last updated
Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.